BDTX Black Diamond Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 5, 2026
$1,89
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$1,60minimo 52 sett.
$4,94massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$109M
P/E (TTM)
-2.6
EPS (TTM)
$-0.73
Ricavi (TTM)
$0
i tuoi badge
Intervallo 52 sett.
$2–$5
Rating Analisti
BUY
Prezzo Obiettivo
$10
P/E
-2.6
ROE
-37.2%
Margine di Profitto Netto
31.9%
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
BDTX Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$1.89
Capitalizzazione di Mercato (MRQ)
$109M
P/E (TTM)
-2.6
EPS (TTM)
$-0.73
Ricavi (TTM)
$0
ROE (TTM)
-37.2%
Intervallo 52 sett.
$2–$5
BDTX Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$70M2018-12-31 → 2025-12-31
EPS$0.392020-12-31 → 2025-12-31
Flusso di cassa libero·2019-12-31 → 2024-12-31
Margine netto31.9%2025-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | BDTX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E (TTM) | -2.6media 5 anni ≈0.2 | ≈0.2 | · | · | |
| P/S | 1.5 | · | 17.2 | Sottovalutato | |
| P/B (MRQ) | 1.1media 5 anni ≈1.1 | ≈1.1 | 1.7 | Sottovalutato | |
| Price / Cash Flow (Prezzo / Flusso di cassa) | 3.7media 5 anni ≈-0.4 | ≈-0.4 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 1.0media 5 anni ≈1.1 | ≈1.1 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | BDTX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Operating Margin (Margine Operativo) | 17.9% | · | -1088.2% | Di prim'ordine | |
| EBITDA Margin (Margine EBITDA) | 17.9% | · | -1088.2% | Di prim'ordine | |
| Net Profit Margin (Margine di Profitto Netto) | 31.9% | · | -988.2% | Di prim'ordine | |
| ROA (TTM) | -29.2%media 5 anni ≈-34.7% | ≈-34.7% | -50.5% | Di prim'ordine | |
| ROE (TTM) | -37.2%media 5 anni ≈-51.7% | ≈-51.7% | -88.6% | Di prim'ordine |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | BDTX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 7.3media 5 anni ≈7.5 | ≈7.5 | 7.5 | In linea | |
| Quick Ratio | 1.3media 5 anni ≈2.2 | ≈2.2 | 4.9 | Bassa liquidità |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | BDTX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 0.5 | · | 0.0 | Di prim'ordine | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$3.3M | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
639.8%
Prossimo report
Nov 04, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 6, 2026 | $-0.17 | $-0.20 | 14.7% |
| 31 Marzo 2026 | Mag 13, 2026 | $-0.16 | $-0.19 | 15.1% |
| 31 Dicembre 2025 | $-0.27 | $-0.19 | -42.1% | |
| 30 Settembre 2025 | $-0.15 | $-0.24 | 37.3% | |
| 30 Giugno 2025 | $-0.19 | $-0.25 | 24.5% | |
| 31 Marzo 2025 | $0.98 | $0.02 | 4416.1% | |
| 31 Dicembre 2024 | $-0.28 | $-0.32 | 12.8% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $70M | $0 | · | · | · | $0 | $0 | $0 | |
| R&D Expense | $34M | $51M | $59M | $64M | $97M | $48M | $22M | $7M | |
| SG&A Expense | $17M | $27M | $27M | $28M | $30M | $21M | $8M | $2M | |
| Operating Expenses | $57M | $79M | $86M | $93M | $127M | $70M | $29M | $9M | |
| Operating Income | $13M | $-79M | $-86M | $-93M | $-127M | $-70M | $-29M | $-9M | |
| Interest Expense | · | · | · | · | $0 | $1.0K | $0 | · | |
| Other Non-op | $6M | $7M | $2M | $-354.0K | $-2M | $-2M | $6.0K | $-16.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $22M | $-70M | $-82M | $-91M | $-126M | $-67M | $-35M | $-9M | |
| EPS (Basic) | $0.39 | $-1.27 | $-1.88 | $-2.52 | $-3.47 | $-2.05 | · | · | |
| EPS (Diluted) | $0.39 | $-1.27 | $-1.88 | $-2.52 | $-3.47 | $-2.05 | · | · | |
| Shares (Basic) | 56,868,111 | 55,028,371 | 43,954,649 | 36,325,586 | 36,189,002 | 32,907,100 | · | · | |
| Shares (Diluted) | 57,562,746 | 55,028,371 | 43,954,649 | 36,325,586 | 36,189,002 | 32,907,100 | · | · | |
| EBITDA | $13M | $-79M | $-86M | $-93M | $-127M | $-70M | $-29M | · |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $36M | $56M | $34M | $66M | $35M | $155M | $52M | |
| Prepaid Expense | $4M | $3M | $3M | $5M | $6M | $4M | $1M | $24.0K | |
| Current Assets | $132M | $101M | $134M | $128M | $216M | $320M | $156M | $52M | |
| PP&E (Net) | $365.0K | $1M | $2M | $3M | $3M | $385.0K | $164.0K | $134.0K | |
| PP&E (Gross) | $2M | $3M | $3M | $3M | $3M | $549.0K | $276.0K | $234.0K | |
| Accum. Depreciation | $1M | $1M | $799.0K | $750.0K | $369.0K | $164.0K | $112.0K | $100.0K | |
| Other Non-current Assets | $73.0K | $249.0K | $0 | $0 | $16.0K | $106.0K | $59.0K | $8.0K | |
| Total Assets | $143M | $123M | $159M | $156M | $248M | $330M | $158M | $52M | |
| Accounts Payable | $579.0K | $4M | $2M | $2M | $4M | $3M | $2M | $416.0K | |
| Accrued Liabilities | $15M | $17M | $17M | $13M | $20M | $12M | $3M | $452.0K | |
| Current Liabilities | $16M | $21M | $20M | $15M | $24M | $14M | $5M | $3M | |
| Capital Leases | $15M | $19M | $22M | $25M | $28M | $8M | · | · | |
| Total Liabilities | $31M | $39M | $42M | $41M | $52M | $22M | $5M | $7M | |
| Common Stock | $8.0K | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $1.0K | $1.0K | |
| Paid-in Capital | $577M | $570M | $534M | $453M | $440M | $425M | $4M | $169.0K | |
| Retained Earnings | $-465M | $-487M | $-417M | $-335M | $-244M | $-118M | $-51M | $-16M | |
| AOCI | $101.0K | $24.0K | $-27.0K | $-2M | $-414.0K | $614.0K | $0 | · | |
| Stockholders' Equity | $112M | $83M | $117M | $116M | $196M | $308M | $-47M | $-16M | |
| Liabilities + Equity | $143M | $123M | $159M | $156M | $248M | $330M | $158M | $52M | |
| Shares Outstanding | 57,138,057 | 56,644,655 | 51,645,557 | 36,434,297 | 36,234,624 | 36,078,383 | 2,236,672 | 2,173,684 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $7M | $11M | $10M | $12M | $14M | $8M | $4M | $64.0K | |
| Restructuring | · | $3M | · | · | · | · | · | · | |
| Operating Cash Flow | $30M | $-62M | $-67M | $-85M | $-100M | $-52M | $-25M | $-8M | |
| CapEx | · | $0 | $33.0K | $192.0K | $3M | $142.0K | $21.0K | $76.0K | |
| Investing Cash Flow | $-45M | $17M | $16M | $53M | $131M | $-282M | $-21.0K | $-76.0K | |
| Stock Issued | $0 | $24M | $72M | $0 | · | · | · | · | |
| Net Stock Activity | $0 | $24M | $72M | · | · | · | · | · | |
| Financing Cash Flow | $-146.0K | $26M | $72M | $177.0K | $729.0K | $215M | $128M | $52M | |
| Net Change in Cash | $-15M | $-20M | $22M | $-32M | $31M | $-119M | $103M | $44M | |
| Free Cash Flow | · | $-62M | $-67M | $-85M | $-103M | $-52M | $-25M | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 17.9% | · | · | · | · | · | · | · | |
| Net Margin | 31.9% | · | · | · | · | · | · | · | |
| EBITDA Margin | 17.9% | · | · | · | · | · | · | · | |
| ROA | 16.8% | -49.5% | -52.4% | -45.1% | -43.5% | -27.6% | -33.6% | · | |
| ROE | 18.3% | -77.1% | -65.7% | -73.2% | -60.6% | -21.2% | 81.1% | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.4 | 4.9 | 6.8 | 8.4 | 9.1 | 22.5 | 32.0 | · | |
| Quick Ratio | 1.3 | 1.8 | 2.9 | 2.2 | 2.8 | 2.4 | 31.8 | · | |
| Interest Coverage | · | · | · | · | · | -69570.0 | · | · |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | · | · | · | · | 0.0 | 0.0 | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.96 | $1.47 | $2.26 | $3.18 | $5.41 | $8.53 | $-21.08 | · | |
| Revenue / Share | $1.22 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $0.51 | $-1.13 | $-1.52 | $-2.34 | $-2.77 | · | · | · | |
| Cash / Share | $0.37 | $0.64 | $1.09 | $0.94 | $1.82 | $0.96 | $69.15 | · | |
| EPS (TTM) | $0.39 | $-1.27 | $-1.88 | $-2.52 | $-3.47 | $-2.05 | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $70M | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income TTM | $22M | $-70M | $-82M | $-91M | $-126M | $-67M | $-35M | · | |
| Market Cap | $139M | $121M | $145M | $66M | $193M | $1.16B | · | · | |
| P/E | 6.2 | -1.7 | -1.5 | -0.7 | -1.5 | -15.6 | · | · | |
| P/S | 2.0 | · | · | · | · | · | · | · | |
| P/B | 1.2 | 1.5 | 1.2 | 0.6 | 1.0 | 3.8 | · | · | |
| P / Tangible Book | 1.2 | 1.5 | 1.2 | 0.6 | 1.0 | 3.8 | · | · | |
| P / Cash Flow | 4.7 | -1.9 | -2.2 | -0.8 | -1.9 | -22.2 | · | · | |
| P / FCF | · | -1.9 | -2.2 | -0.8 | -1.9 | -22.1 | · | · | |
| Earnings Yield | 16.1% | -59.4% | -66.9% | -140.0% | -65.1% | -6.4% | · | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $70M | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| R&D Expense | $7M | $7M | $6M | $7M | $9M | $11M | $12M | $13M | $13M | $14M | $15M | $16M | $13M | $15M | $15M | $16M | |
| SG&A Expense | $5M | $4M | $4M | $4M | $4M | $5M | $6M | $5M | $10M | $7M | $6M | $8M | $7M | $7M | $7M | $6M | |
| Operating Expenses | $12M | $11M | $18M | $11M | $13M | $15M | $18M | $18M | $22M | $20M | $21M | $24M | $20M | $22M | $22M | $22M | |
| Operating Income | $-12M | $-11M | $-18M | $-11M | $-13M | $55M | $-18M | $-18M | $-22M | $-20M | $-21M | $-24M | $-20M | $-22M | $-22M | $-22M | |
| Other Non-op | $1M | $1M | $1M | $1M | $2M | $1M | $2M | $2M | $2M | $1M | $1M | $566.0K | $341.0K | $64.0K | $115.0K | $-92.0K | |
| Income Tax | · | · | · | · | $0 | $226.0K | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-10M | $-9M | $-15M | $-8M | $-11M | $57M | $-16M | $-16M | $-20M | $-18M | $-19M | $-23M | $-19M | $-21M | $-21M | $-22M | |
| EPS (Basic) | $-0.17 | $-0.16 | $-0.27 | $-0.15 | $-0.19 | $1.00 | $-0.28 | $-0.28 | $-0.36 | $-0.35 | $-0.34 | $-0.45 | $-0.52 | $-0.57 | $-0.59 | $-0.60 | |
| EPS (Diluted) | $-0.17 | $-0.16 | $-0.25 | $-0.15 | $-0.19 | $0.98 | $-0.28 | $-0.28 | $-0.36 | $-0.35 | $-0.34 | $-0.45 | $-0.52 | $-0.57 | $-0.59 | $-0.60 | |
| Shares (Basic) | 57,367,283 | 57,233,413 | · | 56,929,103 | 56,803,450 | 56,663,798 | · | 56,507,956 | 55,155,220 | 51,808,849 | · | 50,943,155 | 36,516,114 | 36,483,878 | · | 36,346,181 | |
| Shares (Diluted) | 57,367,283 | 57,233,413 | · | 56,929,103 | 56,803,450 | 57,673,099 | · | 56,507,956 | 55,155,220 | 51,808,849 | · | 50,943,155 | 36,516,114 | 36,483,878 | · | 36,346,181 | |
| EBITDA | $-12M | $-11M | · | $-11M | $-13M | $55M | · | $-18M | $-22M | $-20M | · | $-24M | $-20M | $-22M | · | $-22M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $30M | $21M | $31M | $30M | $98M | $36M | $23M | $33M | $25M | $56M | $58M | $42M | $39M | $34M | $54M | |
| Prepaid Expense | $5M | $5M | $4M | $3M | $4M | $3M | $3M | $3M | $4M | $4M | $3M | $3M | $3M | $5M | $5M | $7M | |
| Current Assets | $115M | $123M | $132M | $139M | $147M | $156M | $101M | $116M | $127M | $119M | $134M | $147M | $93M | $108M | $128M | $151M | |
| PP&E (Net) | $310.0K | $338.0K | $365.0K | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | |
| PP&E (Gross) | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Accum. Depreciation | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $971.0K | $885.0K | $799.0K | $738.0K | $959.0K | $845.0K | $750.0K | $710.0K | |
| Other Non-current Assets | $285.0K | $29.0K | $73.0K | $117.0K | $161.0K | $205.0K | $249.0K | $293.0K | $337.0K | · | $0 | · | · | · | · | $0 | |
| Total Assets | $125M | $133M | $143M | $158M | $166M | $176M | $123M | $138M | $150M | $143M | $159M | $172M | $120M | $136M | $156M | $180M | |
| Accounts Payable | $1M | $3M | $579.0K | $975.0K | $771.0K | $3M | $4M | $2M | $763.0K | $1M | $2M | $694.0K | $3M | $3M | $2M | $6M | |
| Accrued Liabilities | $14M | $12M | $15M | $15M | $16M | $14M | $17M | $19M | $18M | $16M | $17M | $14M | $11M | $10M | $13M | $15M | |
| Current Liabilities | $16M | $15M | $16M | $16M | $17M | $17M | $21M | $21M | $18M | $17M | $20M | $15M | $14M | $13M | $15M | $21M | |
| Capital Leases | $13M | $14M | $15M | $16M | $17M | $18M | $19M | $20M | $21M | $21M | $22M | $23M | $24M | $25M | $25M | $26M | |
| Total Liabilities | $29M | $29M | $31M | $32M | $34M | $35M | $39M | $40M | $39M | $38M | $42M | $38M | $38M | $37M | $41M | $47M | |
| Common Stock | $8.0K | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Paid-in Capital | $580M | $578M | $577M | $576M | $574M | $572M | $570M | $568M | $567M | $540M | $534M | $533M | $458M | $455M | $453M | $450M | |
| Retained Earnings | $-484M | $-474M | $-465M | $-450M | $-441M | $-431M | $-487M | $-471M | $-456M | $-436M | $-417M | $-398M | $-375M | $-356M | $-335M | $-314M | |
| AOCI | $-68.0K | $-36.0K | $101.0K | $142.0K | $-25.0K | $-19.0K | $24.0K | $107.0K | $-115.0K | $-95.0K | $-27.0K | $-364.0K | $-661.0K | $-1M | $-2M | $-2M | |
| Stockholders' Equity | $96M | $104M | $112M | $126M | $133M | $142M | $83M | $97M | $111M | $104M | $117M | $134M | $82M | $98M | $116M | $133M | |
| Liabilities + Equity | $125M | $133M | $143M | $158M | $166M | $176M | $123M | $138M | $150M | $143M | $159M | $172M | $120M | $136M | $156M | $180M | |
| Shares Outstanding | 57,446,349 | 57,301,774 | 57,138,057 | 56,943,413 | 56,886,939 | 56,676,716 | 56,644,655 | 56,521,914 | 56,408,487 | 52,527,626 | 51,645,557 | 51,635,184 | 36,533,525 | 36,511,947 | 36,434,297 | 36,366,206 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $5M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | |
| Operating Cash Flow | $-8M | $-10M | $-7M | $-8M | $-9M | $53M | $-15M | $-11M | $-15M | $-21M | $-14M | $-18M | $-14M | $-20M | $-22M | $-16M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | $0 | $33.0K | $0 | $0 | $0 | $-8.0K | |
| Investing Cash Flow | $-3M | $20M | $-3M | $9M | $-59M | $9M | $28M | $2M | $740.0K | $-14M | $12M | $-38M | $17M | $25M | $2M | $15M | |
| Stock Issued | · | · | $0 | $0 | $0 | $0 | $0 | $-500.0K | $21M | $4M | $0 | $72M | $0 | $0 | $0 | · | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $4M | · | · | · | · | · | · | |
| Financing Cash Flow | $217.0K | $-185.0K | $-196.0K | $134.0K | $-116.0K | $32.0K | $291.0K | $-252.0K | $21M | $4M | $-46.0K | $72M | $0 | $51.0K | $-28.0K | $52.0K | |
| Net Change in Cash | $-11M | $9M | $-10M | $874.0K | $-68M | $62M | $13M | $-9M | $7M | $-31M | $-2M | $16M | $3M | $5M | $-20M | $-2M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-20M | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | 77.9% | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | · | · | · | · | · | 80.8% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | · | · | · | · | · | 77.9% | · | · | · | · | · | · | · | · | · | · | |
| ROA | -6.8% | -5.9% | · | -5.8% | -6.7% | 35.5% | · | -10.0% | -14.8% | -13.1% | · | -13.0% | -12.0% | -11.8% | · | -9.5% | |
| ROE | -8.7% | -7.3% | · | -7.6% | -8.7% | 46.0% | · | -13.4% | -20.6% | -18.0% | · | -17.2% | -16.3% | -15.4% | · | -12.3% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.3 | 8.5 | · | 8.9 | 8.7 | 9.2 | · | 5.6 | 6.9 | 7.0 | · | 9.8 | 6.7 | 8.4 | · | 7.1 | |
| Quick Ratio | 1.2 | 2.1 | · | 2.0 | 1.8 | 5.8 | · | 1.1 | 1.8 | 1.5 | · | 3.8 | 3.0 | 3.0 | · | 2.6 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.4 | · | · | · | · | · | · | · | · | · | · |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.67 | $1.82 | · | $2.22 | $2.33 | $2.50 | · | $1.72 | $1.97 | $1.99 | · | $2.60 | $2.25 | $2.69 | · | $3.66 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.00 | $0.00 | $1.21 | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-0.18 | · | · | · | $0.93 | · | · | · | $-0.41 | · | · | · | $-0.55 | · | · | |
| Cash / Share | $0.33 | $0.52 | · | $0.54 | $0.53 | $1.74 | · | $0.41 | $0.58 | $0.48 | · | $1.12 | $1.15 | $1.07 | · | $1.48 | |
| EPS (TTM) | $-0.73 | $-0.75 | · | $0.36 | $0.23 | $0.06 | · | $-1.33 | $-1.50 | $-1.66 | · | $-2.13 | $-2.28 | $-2.39 | · | $-2.64 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $70M | $70M | $70M | · | · | · | · | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-43M | $-43M | · | $21M | $14M | $5M | · | $-73M | $-81M | $-80M | · | $-84M | $-83M | $-87M | · | $-96M | |
| Market Cap | $106M | $122M | · | $216M | $141M | $88M | · | $246M | $263M | $266M | · | $148M | $184M | $69M | · | $61M | |
| P/E | -2.5 | -2.8 | · | 10.5 | 10.8 | 25.8 | · | -3.3 | -3.1 | -3.1 | · | -1.3 | -2.2 | -0.8 | · | -0.6 | |
| P/S | · | · | · | 3.1 | 2.0 | 1.3 | · | · | · | · | · | · | · | · | · | · | |
| P/B | 1.1 | 1.2 | · | 1.7 | 1.1 | 0.6 | · | 2.5 | 2.4 | 2.6 | · | 1.1 | 2.2 | 0.7 | · | 0.5 | |
| P / Tangible Book | 1.1 | 1.2 | · | 1.7 | 1.1 | 0.6 | · | 2.5 | 2.4 | 2.6 | · | 1.1 | 2.2 | 0.7 | · | 0.5 | |
| P / Cash Flow | · | -11.9 | · | · | · | 1.6 | · | · | · | -12.6 | · | · | · | -3.4 | · | · | |
| Earnings Yield | -39.5% | -35.2% | · | 9.5% | 9.3% | 3.9% | · | -30.6% | -32.2% | -32.7% | · | -74.2% | -45.1% | -126.5% | · | -156.2% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $70M | $0 | · | · | · |
| Margine Operativo % | 17.9% | · | · | · | · |
| Utile netto | $22M | $-70M | $-82M | $-91M | $-126M |
| EPS Diluito | $0.39 | $-1.27 | $-1.88 | $-2.52 | $-3.47 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rapporto corrente | 8.4 | 4.9 | 6.8 | 8.4 | 9.1 |
| Quick Ratio | 1.3 | 1.8 | 2.9 | 2.2 | 2.8 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | · | $-62M | $-67M | $-85M | $-103M |
Proprietari istituzionali (13F) 108 filer · $58.9M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
108
Valore detenuto
$58.9M
Nuove posizioni
27
Posizioni chiuse
30
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 27 (+4 vs trimestre precedente) | 30 (+11 vs trimestre precedente) | 37 (+3 vs trimestre precedente) | 26 (-7 vs trimestre precedente) | -3.0M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| NEA Management Company, LLC | $8.230.200 | 4.448.757 | 13,97% | Azioni |
| BlackRock, Inc. | $7.246.613 | 3.917.088 | 12,30% | Azioni |
| VANGUARD GROUP INC | $5.318.922 | 2.188.857 | 9,03% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $3.931.750 | 2.125.270 | 6,67% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $3.630.429 | 1.962.394 | 6,16% | Azioni |
| Defilade Capital Management, L.P. | $3.098.748 | 1.674.999 | 5,26% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $2.525.486 | 1.365.384 | 4,29% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $2.254.419 | 1.218.171 | 3,83% | Azioni |
| Connor, Clark & Lunn Investment Management Ltd. | $2.021.837 | 1.092.885 | 3,43% | Azioni |
| AWM Investment Company, Inc. | $1.850.000 | 1.000.000 | 3,14% | Azioni |
| MARSHALL WACE, LLP | $1.658.714 | 896.602 | 2,81% | Azioni |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $1.464.153 | 791.434 | 2,48% | Azioni |
| FMR LLC | $1.190.786 | 643.668 | 2,02% | Azioni |
| Balyasny Asset Management L.P. | $1.003.018 | 542.172 | 1,70% | Azioni |
| STATE STREET CORP | $971.274 | 525.013 | 1,65% | Azioni |
| BANK OF AMERICA CORP /DE/ | $765.004 | 413.516 | 1,30% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $753.087 | 407.074 | 1,28% | Azioni |
| NORTHERN TRUST CORP | $675.979 | 365.394 | 1,15% | Azioni |
| Bank of New York Mellon Corp | $589.713 | 318.763 | 1,00% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $573.228 | 309.853 | 0,97% | Azioni |
| PANAGORA ASSET MANAGEMENT INC | $546.068 | 295.172 | 0,93% | Azioni |
| JANE STREET GROUP, LLC | $535.967 | 289.712 | 0,91% | Azioni |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $534.411 | 288.871 | 0,91% | Azioni |
| GOLDMAN SACHS GROUP INC | $534.243 | 288.780 | 0,91% | Azioni |
| STIFEL FINANCIAL CORP | $520.304 | 281.245 | 0,88% | Azioni |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $491.290 | 265.562 | 0,83% | Azioni |
| UBS Group AG | $490.830 | 265.313 | 0,83% | Azioni |
| Empowered Funds, LLC | $459.048 | 248.134 | 0,78% | Azioni |
| MORGAN STANLEY | $427.720 | 231.200 | 0,73% | Azioni |
| TORONTO DOMINION BANK | $395.900 | 214.000 | 0,67% | Opzione Call |
| RITHOLTZ WEALTH MANAGEMENT | $330.186 | 178.479 | 0,56% | Azioni |
| D. E. Shaw & Co., Inc. | $291.079 | 157.340 | 0,49% | Azioni |
| Invesco Ltd. | $243.577 | 131.663 | 0,41% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $199.223 | 107.688 | 0,34% | Azioni |
| CANADA PENSION PLAN INVESTMENT BOARD | $191.660 | 103.600 | 0,33% | Azioni |
| RB Capital Management, LLC | $185.000 | 100.000 | 0,31% | Azioni |
| CITADEL ADVISORS LLC | $166.500 | 90.000 | 0,28% | Opzione Call |
| AMERICAN CENTURY COMPANIES INC | $150.425 | 81.311 | 0,26% | Azioni |
| Quadrature Capital Ltd | $141.906 | 76.706 | 0,24% | Azioni |
| Nuveen, LLC | $119.882 | 64.801 | 0,20% | Azioni |
| RAYMOND JAMES FINANCIAL INC | $115.135 | 62.235 | 0,20% | Azioni |
| CITADEL ADVISORS LLC | $112.850 | 61.000 | 0,19% | Opzione Put |
| Graham Capital Management, L.P. | $100.329 | 54.232 | 0,17% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $97.865 | 52.900 | 0,17% | Opzione Call |
| DEUTSCHE BANK AG\ | $85.170 | 46.038 | 0,14% | Azioni |
| XTX Topco Ltd | $81.957 | 44.301 | 0,14% | Azioni |
| Point72 Asia (Singapore) Pte. Ltd. | $78.121 | 20.613 | 0,13% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $77.700 | 42.000 | 0,13% | Azioni |
| DLK Investment Management, LLC | $75.562 | 16.215 | 0,13% | Azioni |
| LPL Financial LLC | $75.471 | 40.795 | 0,13% | Azioni |
Attivisti e proprietari del 5%+ 3 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Versant Venture Capital VI, L.P., Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Voyageurs I Parallel, L.P., Versant Voyageurs I GP, L.P., Versant Voyageurs I, L.P., Versant Voyageurs I GP Company, Versant Vantage I, L.P., Versant Vantage I GP, L.P., Versant Vantage I GP-GP, LLC ×7 depositi | 08 Agosto 2024 | · | Deposito iniziale | · | SEC |
| New Enterprise Associates 16, L.P., NEA Partners 16, L.P., NEA 16 GP, LLC, Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell, Paul Walker ×2 depositi | 13 Maggio 2024 | · | Deposito iniziale | · | SEC |
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah ×2 depositi | 09 Maggio 2024 | · | Deposito iniziale | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 22 insider · 10 dirigenti · 12 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Mark A. Velleca | PRESIDENT & CEO | 21 Gennaio 2026 A | 121.522 | 0 | 0 | $0 |
| David M. Epstein | Officer Title: President and Chief Executive Officer | 27 Giugno 2023 S | 671.423 | 0 | 0 | $0 |
| Fang Ni | Officer Title: Chief Business Officer and Chief Financial Officer | 14 Febbraio 2024 A | 125.389 | 0 | 0 | $0 |
| Thomas Leggett | Chief Financial Officer | 17 Febbraio 2021 A | 0 | 0 | 0 | $0 |
| Brent Hatzis-Schoch | Officer Title: Chief Operating Officer and General Counsel | 21 Gennaio 2026 A | 83.400 | 0 | 0 | $0 |
| Erika Jones | Officer Title: Senior Vice President, Finance and Corporate Controller | 21 Gennaio 2026 A | 85.150 | 0 | 0 | $0 |
| Elizabeth Buck | CHIEF SCIENTIFIC OFFICER | 21 Gennaio 2026 A | 170.192 | 0 | 0 | $0 |
| Sergey Yurasov | CHIEF MEDICAL OFFICER | 21 Gennaio 2026 A | 75.000 | 0 | 0 | $0 |
| Christopher D. Roberts | Chief Scientific Officer | 05 Aprile 2021 M | 3.200 | 0 | 0 | $0 |
| Rachel Humphrey | Chief Medical Officer | 17 Febbraio 2021 A | 10.000 | 0 | 0 | $0 |
| Prakash Raman | Direttore | 18 Settembre 2026 A | 51.840 | 0 | 0 | $0 |
| Ali Behbahani | Direttore | 18 Settembre 2026 A | 110.236 | 0 | 0 | $0 |
| Shannon Campbell | Direttore | 26 Giugno 2026 A | 8.865 | 0 | 0 | $0 |
| Samarth Kulkarni | Direttore | 26 Giugno 2026 A | · | 0 | 0 | $0 |
| Garry E Menzel | Direttore | 26 Giugno 2026 A | 51.825 | 0 | 0 | $0 |
| Kapil Dhingra | Direttore | 26 Giugno 2026 A | · | 0 | 0 | $0 |
| Wendy L Dixon | Direttore | 15 Marzo 2024 A | 38.054 | 0 | 0 | $0 |
| Alexander Mayweg | Direttore | 16 Maggio 2023 A | · | 0 | 0 | $0 |
| Rajeev Shah | Direttore | 16 Maggio 2023 A | 0 | 0 | 0 | $0 |
| Bradley J Bolzon PhD | Direttore | 18 Giugno 2021 A | 21.851 | 0 | 0 | $0 |
| Robert Alexander Ingram | · | 16 Dicembre 2022 A | 42.854 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | · | 03 Febbraio 2020 C | 568.185 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 16 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| IWC · iShares Trust | 0,02% | 158.433 SH | 11 Settembre 2026 | Giornaliero |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 41.055 SH | 19 Agosto 2026 | Giornaliero |
| IBB · iShares Trust | 0,01% | 369.985 SH | 11 Settembre 2026 | Giornaliero |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,01% | 3.996 SH | 01 Ottobre 2026 | Giornaliero |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 9.610 SH | 01 Ottobre 2026 | Giornaliero |
| DFSV · Dimensional ETF Trust | 0,00% | 210.208 NS | 31 Luglio 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 1.187.063 SH | 11 Settembre 2026 | Giornaliero |
| RSSL · Global X Funds | 0,00% | 22.531 NS | 31 Luglio 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 31.143 SH | 30 Settembre 2026 | Giornaliero |
| DFAS · Dimensional ETF Trust | 0,00% | 62.435 NS | 31 Luglio 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 35.761 NS | 31 Luglio 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 511.250 SH | 19 Agosto 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.556.251 SH | 19 Agosto 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 272.839 SH | 19 Agosto 2026 | Giornaliero |
| IWN · iShares Trust | · | 462.815 SH | 11 Settembre 2026 | Giornaliero |
| SMLF · iShares Trust | · | 477.103 SH | 11 Settembre 2026 | Giornaliero |
BDTX Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 14 analisti
COMPRA
Target mediano
$10.00
+429,1%
5 35,7%
Acquisto forte
7 50,0%
Compra
2 14,3%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
7 analisti · 2026-09-28Target medio $10.00 +429,1%
← Sotto tutti i target
Prezzo attuale $1.89
Basso$8.00
Media$10.00
Alto$14.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| BDTX | $139M | 6.2 | · | 31.9% | 18.3% | · |
| GNLX | $166M | -5.1 | 0.00% | -401812.5% | -181.4% | · |
| XGN | $139M | -6.5 | 19.7% | -30.0% | -103.7% | 58.3% |
| COYA | $121M | -4.6 | 123.6% | -267.1% | -59.5% | · |
| CADL | $310M | -7.8 | · | · | -53.7% | · |
| OKUR | · | -0.7 | · | -1733.7% | -88.6% | · |
| ANIX | $136M | -12.1 | 0.00% | · | -62.2% | · |
| EQ | $95M | -4.0 | 13.9% | · | -133.1% | · |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 5, 2026